Globus Medical (GMED) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Globus Medical Revenue Highlights


Latest Revenue (Y)

$1.57B

Latest Revenue (Q)

$629.69M

Main Segment (Y)

Spine

Main Geography (Y)

Non Us

Globus Medical Revenue by Period


Globus Medical Revenue by Year

DateRevenueChange
2023-12-31$1.57B53.34%
2022-12-31$1.02B6.76%
2021-12-31$958.10M21.43%
2020-12-31$789.04M0.47%
2019-12-31$785.37M10.15%
2018-12-31$712.97M12.11%
2017-12-31$635.98M12.76%
2016-12-31$563.99M3.53%
2015-12-31$544.75M14.84%
2014-12-31$474.37M9.19%
2013-12-31$434.46M12.56%
2012-12-31$385.99M16.45%
2011-12-31$331.48M15.02%
2010-12-31$288.19M13.31%
2009-12-31$254.34M-

Globus Medical generated $1.57B in revenue during NA 2023, up 53.34% compared to the previous quarter, and up 219.99% compared to the same period a year ago.

Globus Medical Revenue by Quarter

DateRevenueChange
2024-06-30$629.69M3.80%
2024-03-31$606.67M-1.60%
2023-12-31$616.53M60.71%
2023-09-30$383.64M31.56%
2023-06-30$291.62M5.39%
2023-03-31$276.69M0.80%
2022-12-31$274.50M8.01%
2022-09-30$254.15M-3.60%
2022-06-30$263.65M14.36%
2022-03-31$230.55M-7.79%
2021-12-31$250.02M8.84%
2021-09-30$229.72M-8.48%
2021-06-30$251.02M10.41%
2021-03-31$227.34M-2.61%
2020-12-31$233.44M8.03%
2020-09-30$216.10M45.11%
2020-06-30$148.92M-21.86%
2020-03-31$190.58M-9.96%
2019-12-31$211.67M7.88%
2019-09-30$196.22M0.86%
2019-06-30$194.54M6.34%
2019-03-31$182.95M-6.63%
2018-12-31$195.94M15.78%
2018-09-30$169.24M-2.39%
2018-06-30$173.38M-0.59%
2018-03-31$174.41M-0.92%
2017-12-31$176.03M16.01%
2017-09-30$151.74M-0.42%
2017-06-30$152.39M-2.19%
2017-03-31$155.81M2.78%
2016-12-31$151.59M11.75%
2016-09-30$135.65M-1.34%
2016-06-30$137.49M-1.27%
2016-03-31$139.26M-2.33%
2015-12-31$142.59M4.08%
2015-09-30$136.99M2.56%
2015-06-30$133.57M1.49%
2015-03-31$131.60M2.18%
2014-12-31$128.80M9.35%
2014-09-30$117.79M3.71%
2014-06-30$113.57M-0.56%
2014-03-31$114.21M-0.90%
2013-12-31$115.25M7.52%
2013-09-30$107.19M0.17%
2013-06-30$107.01M1.90%
2013-03-31$105.02M4.46%
2012-12-31$100.54M6.09%
2012-09-30$94.76M-1.26%
2012-06-30$95.98M1.33%
2012-03-31$94.72M7.64%
2011-12-31$87.99M4.42%
2011-09-30$84.27M4.12%
2011-06-30$80.94M3.39%
2011-03-31$78.28M-

Globus Medical generated $629.69M in revenue during Q2 2024, up 3.80% compared to the previous quarter, and up 227.58% compared to the same period a year ago.

Globus Medical Revenue Breakdown


Globus Medical Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22Dec 21Dec 20Dec 19
Emerging Technology$120.22M$96.14M$81.32M$40.60M$46.99M
Spine$1.45B$926.70M$876.78M$748.45M$738.38M

Globus Medical's latest annual revenue breakdown by segment (product or service), as of Dec 23: Spine (92.34%), and Emerging Technology (7.66%).

Quarterly Revenue by Product

Product/ServiceMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Emerging Technology$31.97M$32.71M$27.66M$34.76M$25.08M$29.50M$24.09M$29.41M$13.15M$25.40M$20.24M$20.75M$14.93M$18.08M$9.04M$5.44M$8.04M$13.91M$13.89M$7.19M
Spine$574.70M$592.34M$347.46M$256.86M$251.61M$245.00M$230.06M$234.24M$217.40M$224.62M$209.48M$230.26M$212.42M$215.36M$207.06M$143.48M$182.54M$197.76M$182.32M$175.76M

Globus Medical's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Spine (94.73%), and Emerging Technology (5.27%).

Globus Medical Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 23Dec 22Dec 21Dec 20Dec 19
Non Us$288.71M$150.90M$138.53M$124.59M$137.69M
U-$871.94M$819.57M$664.45M$647.68M

Globus Medical's latest annual revenue breakdown by geography, as of Dec 23: Non Us (100.00%).

Quarterly Revenue by Country

CountryMar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22Mar 22Dec 21Sep 21Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19
Non Us$123.74M$125.69M$74.32M$46.13M$42.57M$41.27M$37.12M$38.37M$34.15M$37.06M$31.55M$35.90M$34.03M$34.70M$33.99M$23.77M$32.13M$34.21M$33.52M$34.55M
U---$245.49M$234.12M$233.23M$217.02M$225.28M$196.40M$212.96M$198.17M$215.12M$193.32M$198.75M$182.10M$125.15M$158.45M$177.46M$162.70M$159.99M

Globus Medical's latest quarterly revenue breakdown by geography, as of Mar 24: Non Us (100.00%).

Globus Medical Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
BRKRBruker$2.96B$800.70M
PODDInsulet$1.70B$488.50M
ITGRInteger$1.60B$746.27M
GMEDGlobus Medical$1.57B$629.69M
CNMDCONMED$1.24B$316.70M
LIVNLivaNova$1.15B$318.11M
INSPInspire Medical Systems$624.80M$195.88M
NVCRNovoCure$509.34M$155.09M
NARIInari Medical$493.63M$153.39M
IRTCiRhythm$492.68M$147.54M
ATECAlphatec$482.26M$47.99M
NVRONevro$425.17M$101.90M
GKOSGlaukos$314.71M$95.69M
OFIXOrthofix Medical$100.00K$198.62M

GMED Revenue FAQ


Globus Medical's yearly revenue for 2023 was $1.57B, representing an increase of 53.34% compared to 2022. The company's yearly revenue for 2022 was $1.02B, representing an increase of 6.76% compared to 2021. GMED's yearly revenue for 2021 was $958.1M, representing an increase of 21.43% compared to 2020.

Globus Medical's quarterly revenue for Q2 2024 was $629.69M, a 3.80% increase from the previous quarter (Q1 2024), and a 115.93% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $606.67M, a -1.60% decrease from the previous quarter (Q4 2023), and a 119.26% increase year-over-year (Q1 2023). GMED's quarterly revenue for Q4 2023 was $616.53M, a 60.71% increase from the previous quarter (Q3 2023), and a 124.60% increase year-over-year (Q4 2022).

Globus Medical's revenue growth rate for the last 3 years (2021-2023) was 63.71%, and for the last 5 years (2019-2023) was 99.71%.

Globus Medical's revenue streams in c 23 are Emerging Technology, and Spine. Emerging Technology generated $120.22M in revenue, accounting 7.66% of the company's total revenue, up 25.04% year-over-year. Spine generated $1.45B in revenue, accounting 92.34% of the company's total revenue, up 56.28% year-over-year.

For the fiscal year ending Dec 23, the largest source of revenue of Globus Medical was Spine. This segment made a revenue of $1.45B, representing 92.34% of the company's total revenue.